Guthart Gary S sold 10,000 shares of INTUITIVE SURGICAL INC at $457.34 for −$4.57M on Nov 4, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Director
DIR
Filed Nov 5, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$4,573,370Shares × reported price
Shares traded
10,000Common Stock
Price per share
$457.34Reported price. Read footnotes for ranges.
% of reported position traded
0.83%This security and ownership context
Holdings after
1,194,530Indirect · by Trust
Trade date
Nov 4, 2026Sell
Filed
Nov 5, 2026, 1:38 PM ET1-day reporting delay
Accession
0001280628-26-000018Code S · Transaction 393244
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 1,204,530 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

ISRG price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
ISRG · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −13%1w ago −5.2%1d ago −5.9%
Returns since7d −4.1%30d90d180d1y

Footnotes in full

F1: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 15, 2027. F2: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $453.69 to $458.27 as follows: 720 shares sold at $453.69 to $454.11; 1,845 shares sold at $455.00 to $455.15; 200 shares sold at $456.93; and 7,235 shares sold at $458.27. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.